Drugs / CD34+ cells
last change Apr 2013 re-read 3 minutes ago

CD34+ cells

Cell therapy

Developed for
dilated cardiomyopathy
Investigated by
Blood Transfusion Centre of Slovenia · Stanford University · University Medical Centre Ljubljana

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00629018 May 2006 → Apr 2013 dilated cardiomyopathy University Medical Centre Ljubljana Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as CD34+ cells “peripheral blood CD34+ cells were mobilized by granulocyte-colony stimulating factor and collected via apheresis. Patients underwent myocardial scintigraphy and CD34+ cells...” PMID 21440864 ↗ Dec 2010
Modality Cell therapy “intracoronary CD34+ cell transplantation” NCT00629018 ↗
Route Other “CD34+ cells will be injected intracoronary” NCT00629018 ↗